Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
ACS Chemical Biology
|
January 17, 2009
Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria
Tina Dasgupta, Penchit Chitnumsub, Sumalee Kamchonwongpaisan, et al.
Journal of the American Chemical Society
|
July 1, 2008
Optimization of azoles as anti-human immunodeficiency virus agents guided by free-energy calculations
Jacob G Zeevaart, Ligong Wang, Vinay V Thakur, et al.
ACS Medicinal Chemistry Letters
|
December 16, 2020
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
Mohammad M Ghahremanpour, Julian Tirado-Rives, Maya Deshmukh, et al.
Biorxiv : the Preprint Server for Biology
|
September 2, 2020
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
Mohammad M Ghahremanpour, Julian Tirado-Rives, Maya Deshmukh, et al.
Journal of Medicinal Chemistry
|
May 11, 2013
Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy
Christopher M Bailey, Todd J Sullivan, Pinar Iyidogan, et al.
The Journal of Biological Chemistry
|
October 27, 2007
Pre-steady-state kinetic studies establish entecavir 5'-triphosphate as a substrate for HIV-1 reverse transcriptase
Robert A Domaoal, Moira McMahon, Chloe L Thio, et al.
Journal of Medicinal Chemistry
|
May 2, 2003
Molecular modeling calculations of HIV-1 reverse transcriptase nonnucleoside inhibitors: correlation of binding energy with biological activity for novel 2-aryl-substituted benzimidazole analogues
Marilyn B Kroeger Smith, Brian M Hose, Arie Hawkins, et al.
ACS Central Science
|
March 31, 2021
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
Chun-Hui Zhang, Elizabeth A Stone, Maya Deshmukh, et al.
ACS Medicinal Chemistry Letters
|
August 19, 2021
Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency
Chun-Hui Zhang, Krasimir A Spasov, Raquel A Reilly, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
ACS Chemical Biology
|
January 17, 2009
Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria
Tina Dasgupta, Penchit Chitnumsub, Sumalee Kamchonwongpaisan, et al.
Journal of the American Chemical Society
|
July 1, 2008
Optimization of azoles as anti-human immunodeficiency virus agents guided by free-energy calculations
Jacob G Zeevaart, Ligong Wang, Vinay V Thakur, et al.
ACS Medicinal Chemistry Letters
|
December 16, 2020
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
Mohammad M Ghahremanpour, Julian Tirado-Rives, Maya Deshmukh, et al.
Biorxiv : the Preprint Server for Biology
|
September 2, 2020
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
Mohammad M Ghahremanpour, Julian Tirado-Rives, Maya Deshmukh, et al.
Journal of Medicinal Chemistry
|
May 11, 2013
Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy
Christopher M Bailey, Todd J Sullivan, Pinar Iyidogan, et al.
The Journal of Biological Chemistry
|
October 27, 2007
Pre-steady-state kinetic studies establish entecavir 5'-triphosphate as a substrate for HIV-1 reverse transcriptase
Robert A Domaoal, Moira McMahon, Chloe L Thio, et al.
Journal of Medicinal Chemistry
|
May 2, 2003
Molecular modeling calculations of HIV-1 reverse transcriptase nonnucleoside inhibitors: correlation of binding energy with biological activity for novel 2-aryl-substituted benzimidazole analogues
Marilyn B Kroeger Smith, Brian M Hose, Arie Hawkins, et al.
ACS Central Science
|
March 31, 2021
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
Chun-Hui Zhang, Elizabeth A Stone, Maya Deshmukh, et al.
ACS Medicinal Chemistry Letters
|
August 19, 2021
Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency
Chun-Hui Zhang, Krasimir A Spasov, Raquel A Reilly, et al.
Page
of 7